User:Mr. Ibrahem/Eribulin

Eribulin, sold under the brand name Halaven, is a medication used to treat breast cancer and liposarcoma. It is used when other treatments have failed. It is given by injection into a vein.

Common side effects include tiredness, hair loss, peripheral nerve damage, abdominal pain, fever, low white blood cells, and low red blood cells. Other side effects may include low potassium, low calcium, and QT prolongation. Use in pregnancy may harm the baby. It is a microtubule inhibitor.

Eribulin was approved for medical use in the United States in 2010 and Europe in 2011. In the United Kingdom 0.88 mg cost the NHS about £360 as of 2021. This amount in the United States costs about 580 USD.